packageEvolocumab

evolocumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Evolocumab, a monoclonal antibody that lowers cholesterol, is used to treat dyslipidemias such as hypercholesterolemia and related conditions including coronary artery disease. It is authorised in the European Union and is widely used as a lipid-modifying agent.

Summary written by glm-5.3-flash from Wikidata Q15623825 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:evolocumab
ATC codes:C10AX13
DrugBank:DB09303
Wikidata:Q15623825
molar mass:141800 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown